Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2026-03-15 @ 1:23 PM
Study NCT ID:
NCT01115920
Status:
COMPLETED
Last Update Posted:
2010-11-18
First Post:
2010-04-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of Intravenous (IV) Infusion of MTP-131 (Bendavia™) in Healthy Adults
Sponsor:
Stealth BioTherapeutics Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SPIRI-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Richard Straube, MD, Chief Medical Officer
Old Organization:
Stealth Peptides, Inc.